Abbott LaboratoriesXSWX:ABT 80 Buyback Yield % is 0.49 as of Jun. 30, 2026, which is 7% above its 10-year median of 0.46. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF106.15. Among 345 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 73.91% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Abbott Laboratories Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ABT vs SYK, MDT, BSX: Buyback Yield % Comparison
For the Medical Devices subindustry, Abbott Laboratories's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (XSWX:ABT) has a Buyback Yield % of 0.49 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Abbott Laboratories and its competitors. This is near median its historical median of 0.46. Over the past decade, Abbott Laboratories' Buyback Yield % has ranged from 0.11 to 2.44. According to the industry distribution chart, Abbott Laboratories ranks #90 out of 345 companies in the Medical Devices & Instruments industry, placing it in the top 26.1%.
Is Abbott Laboratories' Buyback Yield % too high?
Abbott Laboratories' current Buyback Yield % of 0.49 is near median its 10-year median of 0.46. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 2.44. Based on the distribution chart, Abbott Laboratories ranks #90 out of 345 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Buyback Yield % compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #90 out of 345 companies for Buyback Yield %. This puts Abbott Laboratories in the upper half of its industry. Historically, Abbott Laboratories' own Buyback Yield % has ranged from 0.11 to 2.44 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Buyback Yield % is 0.49, which is near median its own 10-year median of 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Buyback Yield % of 0.49. The stock's GF Value™ is CHF106.15, compared to a current price of CHF76.00 — trading 28.4% below its estimated fair value. The current Buyback Yield % is 0.49, which is near median its 10-year median of 0.46. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Buyback Yield % is 0.49 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of CHF76.00 is trading 28.4% below its estimated GF Value™ of CHF106.15.
Key valuation signals for XSWX:ABT:
Buyback Yield %: 0.49 (near median its 10-year median of 0.46)
GF Value™: CHF106.15 vs. price of CHF76.00 (28.4% below fair value)
No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for XSWX:ABT
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ABT has been successfully added to your 
